Neurology Times Staff

A look into the numerous education series upcoming in 2021 by the Tuberous Sclerosis Alliance

What does compensation for neurologists look like these days? Would you choose neurology all over again?

Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of headache attacks.

Chronic pain, sleep disorders, neuropathy, and anxiety were the most common conditions that showed improvement in the study.

Do you want to make your voice heard? Then join the Neurology Times Advisory Board!

If you could bring only one book or film with you to a desert island, what would it be?

If your patient manifests signs that are compatible with Alzheimer disease, should you recommend olive oil as part of a prevention and treatment regimen? This and other questions answered by Domenico Pratico, MD.

This infographic spotlights the most common unexpected claim denials in medicine nationwide, with a special focus on neurology.